| Source: |
| Type: |
| A pro-apoptotic protein that plays a crucial role in regulating cell death, particularly in the context of cancer. BIM is a member of the BCL-2 family of proteins, which are key regulators of apoptosis (programmed cell death). BIM cancer is characterized by the overexpression of the BIM protein, which is a pro-apoptotic protein that promotes cell death. BIM protein has been shown to have both tumor-suppressive and tumor-promoting roles, depending on the context. High BIM expression: Melanoma, lung, breast, colorectal. Low BIM expression: Leukemia, Lymphoma, Prostate The expression of BIM can serve as a prognostic marker in several cancers. Higher levels of BIM are often associated with increased apoptosis and better treatment responses, while lower levels may indicate resistance to therapy and poorer outcomes. |
| 3288- | SIL, | Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:483 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid